APT Therapeutics' Incubator/Accelerator Round

APT Therapeutics raised a round of funding on , . Investors include Nidus Center for Scientific Enterprise.

APT Therapeutics develops acute-use drugs for controlling clot formation in stroke, pulmonary embolism, myocardial infarction, deep vein thrombosis, and transplantation.…

Articles about APT Therapeutics' Incubator/Accelerator Round: